Altered glycosylation in donor mice causes rejection of strain-matched skin and heart grafts

American Journal of Transplantation

Volumn 14, Issue 4, 2014, Pages 797-805

  Gock, H ^a   Murray Segal, L J ^a   Winterhalter, A C ^a   Aminian, A ^a   Moore, G T C ^a   Brown, S J ^a   D'Apice, A J F ^a,b   Cowan, P J ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Animal models; innate immunity; NK cells; O blood group; skin grafts; transgenic mouse

Indexed keywords

FUCOSYLTRANSFERASE; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CONTROLLED STUDY; DONOR; FLOW CYTOMETRY; FUCOSYLATION; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SKIN GRAFT; SKIN GRAFT REJECTION; SKIN TRANSPLANTATION; SURVIVAL TIME; T CELL DEPLETION; XENOTRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL; ENZYME IMMUNOASSAY; FEMALE; GENETICS; GLYCOSYLATION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; METABOLISM; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; T LYMPHOCYTE; TRANSGENIC MOUSE; XENOGRAFT;

ANIMALS; ANTIGEN PRESENTATION; FEMALE; FUCOSYLTRANSFERASES; GLYCOSYLATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOENZYME TECHNIQUES; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROGNOSIS; RISK FACTORS; SKIN TRANSPLANTATION; SURVIVAL RATE; T-LYMPHOCYTES; TISSUE DONORS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84897112237     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12634     Document Type: Article

References (33)

1. Johnson JL, Jones MB, Ryan SO, Cobb BA., The regulatory power of glycans and their binding partners in immunity. Trends Immunol 2013; 34: 290-298.
2. Lauc G, Huffman JE, Pucic M, et al. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet 2013; 9: e1003225.
3. Thanabalasingham G, Huffman JE, Kattla JJ, et al. Mutations in HNF1A result in marked alterations of plasma glycan profile. Diabetes 2013; 62: 1329-1337.
4. Chen CG, Fisicaro N, Shinkel TA, et al. Reduction in Gal-α1,3-Gal epitope expression in transgenic mice expressing human H-transferase. Xenotransplantation 1996; 3: 69-75.
5. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1: 1261-1267.
6. Brown SJ, Miller AM, Cowan PJ, et al. Altered immune system glycosylation causes colitis in alpha1,2-fucosyltransferase transgenic mice. Inflamm Bowel Dis 2004; 10: 546-556.
7. Murray-Segal L, Gock H, Cowan PJ, d'Apice AJ., Anti-Gal antibody-mediated skin graft rejection requires a threshold level of Gal expression. Xenotransplantation 2008; 15: 20-26.
8. Shinkel TA, Chen CG, Salvaris E, et al. Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997; 64: 197-204.
9. Moore GT, Brown SJ, Winterhalter AC, et al. Glycosylation changes in hFUT1 transgenic mice increase TCR signaling and apoptosis resulting in thymocyte maturation arrest. Mol Immunol 2008; 45: 2401-2410.
10. Hidalgo A, Weiss LA, Frenette PS., Functional selectin ligands mediating human CD34(+) cell interactions with bone marrow endothelium are enhanced postnatally. J Clin Invest 2002; 110: 559-569.
11. Mottram PL, Han WR, Murray-Segal LJ, Mandel TE, Pietersz GA, McKenzie IF., Idarubicin-anti-CD3: A new immunoconjugate that induces alloantigen-specific tolerance in mice. Transplantation 1997; 64: 684-690.
12. Purcell LJ, Mottram PL, Mandel TE., Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation. Immunol Cell Biol 1993; 71: 349-352.
13. Gock H, Murray-Segal L, Salvaris E, Cowan PJ, D'Apice AJ., Gal mismatch alone causes skin graft rejection in mice. Transplantation 2002; 74: 637-645.
14. Gock H, Salvaris E, Murray-Segal L, et al. Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice. Xenotransplantation 2000; 7: 237-246.
15. Eberle AB, Lykke-Andersen S, Muhlemann O, Jensen TH., SMG6 promotes endonucleolytic cleavage of nonsense mRNA in human cells. Nat Struct Mol Biol 2009; 16: 49-55.
16. Redon S, Reichenbach P, Lingner J., Protein RNA and protein protein interactions mediate association of human EST1A/SMG6 with telomerase. Nucleic Acids Res 2007; 35: 7011-7022.
17. Simpson E, Scott D, James E, et al. Minor H antigens: Genes and peptides. Transpl Immunol 2002; 10: 115-123.
18. Benichou G, Yamada Y, Yun SH, Lin C, Fray M, Tocco G., Immune recognition and rejection of allogeneic skin grafts. Immunotherapy 2011; 3: 757-770.
19. Madsen L, Labrecque N, Engberg J, et al. Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci USA 1999; 96: 10338-10343.
20. Jessen B, Maul-Pavicic A, Ufheil H, et al. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. Blood 2011; 118: 4620-4629.
21. Chiang SC, Theorell J, Entesarian M, et al. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. Blood 2013; 121: 1345-1356.
22. Lee RT, Hsu TL, Huang SK, Hsieh SL, Wong CH, Lee YC., Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities. Glycobiology 2011; 21: 512-520.
23. Martinez-Pomares L., The mannose receptor. J Leukoc Biol 2012; 92: 1177-1186.
24. Mandal TK, Mukhopadhyay C., Effect of glycosylation on structure and dynamics of MHC class I glycoprotein: A molecular dynamics study. Biopolymers 2001; 59: 11-23.
25. Hartmann J, Tran TV, Kaudeer J, et al. The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding. J Biol Chem 2012; 287: 31527-31539.
26. Kroemer A, Xiao X, Degauque N, et al. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008; 180: 7818-7826.
27. Kerdiles Y, Ugolini S, Vivier E., T cell regulation of natural killer cells. J Exp Med 2013; 210: 1065-1068.
28. Hu X, Liu G, Hou Y, et al. Induction of M2-like macrophages in recipient NOD-scid mice by allogeneic donor CD4(+)CD25(+) regulatory T cells. Cell Mol Immunol 2012; 9: 464-472.
29. Liu W, Xiao X, Demirci G, Madsen J, Li XC., Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms. J Immunol 2012; 188: 2703-2711.
30. Mazumder R, Morampudi KS, Motwani M, Vasudevan S, Goldman R., Proteome-wide analysis of single-nucleotide variations in the N-glycosylation sequon of human genes. PLoS ONE 2012; 7: e36212.
31. Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092.
32. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20: 251-255.
33. Lutz AJ, Li P, Estrada JL, et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose alpha-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 2013; 20: 27-35.